2030년까지 북미 제약 계약 판매 조직 시장 예측 - 지역 분석 - 서비스(상업 서비스 및 비상업 서비스), 모듈(신디케이트 모듈 및 전용 모듈), 치료 영역(심장혈관 장애, 종양학, 대사 장애, 신경학, 정형외과 질환)별 , 전염병 등) 및 최종 사용자(바이오의약품 회사 및 제약 회사)

BMIRE00030017 | Pages: 86 | Pharmaceuticals | Apr 2024 | Type: Regional | Status: Published
북미 의약품 계약 판매 조직 시장은 2022년 39억 8,729만 달러에서 2030년 76억 1,412만 달러로 성장할 것으로 예상됩니다. 2022년부터 2030년까지 연평균 성장률(CAGR) 8.4%를 기록할 것으로 예상됩니다. 디지털 기술의 통합이 북미를 주도합니다. 제약 계약 판매 조직 시장 디지털 기술의 확산이 증가하면서 제약 계약 판매 조직(CSO) 시장의 변혁이 급증하고 있습니다. 이러한 근본적인 변화는 역동적으로 변화하는 제약 시장에 대한 전술적 대응의 필요성을 강조합니다. 영업 운영을 합리화하고, 생산성을 높이며, 점점 디지털화되는 의료 환경의 복잡성을 헤쳐나가기 위한 필수 구성 요소는 디지털 도구와 기술을 CSO에 통합하는 것입니다. 고급 고객 관계 관리 도구, 인공 지능 및 데이터 분석을 통해 CSO는 귀중한 통찰력을 얻고, 판매 전략을 맞춤화하며, 의료 전문가와 더 깊은 관계를 구축할 수 있습니다. 정보 전송 속도를 높이는 것 외에도 디지털 플랫폼의 원활한 통합을 통해 시장 동향 및 입법 변화에 실시간으로 적응할 수 있습니다. 제약 CSO 환경의 이러한 기술적 변화는 단순한 유행 이상의 의미를 갖습니다. 이는 영업 전략을 개발하고 구현하는 방법을 근본적으로 재정의하는 것을 나타냅니다. 디지털 기술의 채택으로 CSO는 혁신의 최전선에 서게 됩니다. 이는 의료 부문을 휩쓸고 있는 더 큰 규모의 디지털 혁신에 맞춰 보다 대응력이 뛰어난 환경을 촉진합니다. 제약 CSO가 기술 전문성, 전략적 민첩성, 제약 생태계의 현대 수요에 대한 명확한 인식의 융합을 통해 추진되는 디지털화의 힘을 계속 사용함에 따라 시장은 지속적인 성장을 이룰 수 있는 위치에 있습니다. 북미 제약 계약 판매 조직 시장 개요 북미의 제약 계약 판매 조직 시장은 미국, 캐나다 및 멕시코로 구분됩니다. 2022년에는 미국이 이 지역에서 가장 큰 시장 점유율을 차지했으며 예측 기간 동안 계속해서 지배력을 유지할 것으로 예상됩니다. 북미 의약품 위탁판매기관 시장은 위탁판매기관의 신기술 도입, 제약회사의 저분자·바이오의약품 판매 확대에 대한 강조, 절단에 대한 집중 증가로 성장이 예상된다. 사내 판매 운영으로 인해 발생하는 비용을 줄이는 것이 북미 제약 계약 판매 조직 시장의 성장을 이끄는 주요 요인입니다. 시간이 지나면서 신약 출시 횟수가 급증했습니다. IQVIA의 R&D 동향 보고서에 따르면 2021년 전 세계적으로 84개의 새로운 활성 화합물이 도입되었으며 이는 지난 5년 동안 도입된 것보다 두 배나 많은 수치입니다. 국제적으로 의약품 출시가 증가함에 따라 계약 판매 서비스에 대한 수요도 증가할 것으로 예상됩니다. 북미는 의약품 계약 판매 조직 시장에서 가장 큰 점유율을 차지합니다. EPS Corp.와 같은 주요 플레이어; IQVIA, Inc.; Axxelus는 이 지역 시장에 활력을 불어넣고 있습니다. 북미 제약 계약 판매 조직 시장 수익 및 2030년 예측(미화 백만 달러) 북미 제약 계약 판매 조직 시장 세분화 북미 제약 계약 판매 조직 시장은 서비스, 모듈, 치료 영역, 최종 사용자 및 국가로 분류됩니다. 서비스를 기반으로 북미 제약 계약 판매 조직 시장은 상업 서비스와 비상업 서비스로 구분됩니다. 상업 서비스 부문은 2022년 북미 제약 계약 판매 조직 시장에서 더 큰 점유율을 차지했습니다. 모듈을 기준으로 북미 제약 계약 판매 조직 시장은 신디케이트된 모듈과 전용 모듈로 구분됩니다. 신디케이트된 모듈 부문은 2022년 북미 제약 계약 판매 조직 시장에서 더 큰 점유율을 차지했습니다. 치료 영역을 기준으로 북미 제약 계약 판매 조직 시장은 심혈관 질환, 종양학, 대사 장애, 신경학, 정형외과 질환, 감염성 질환으로 분류됩니다. 질병 및 기타. 종양학 부문은 2022년 북미 제약 계약 판매 조직 시장에서 가장 큰 점유율을 차지했습니다. 최종 사용자를 기준으로 북미 제약 계약 판매 조직 시장은 바이오제약 회사와 제약 회사로 구분됩니다. 제약 회사 부문은 2022년 북미 제약 계약 판매 조직 시장에서 더 큰 점유율을 차지했습니다. 국가를 기준으로 북미 제약 계약 판매 조직 시장은 미국, 캐나다 및 멕시코로 분류됩니다. 미국은 2022년 북미 의약품 계약 판매 조직 시장을 장악했습니다. Aenova Holding GmbH, Axxelus Inc, CMIC Holdings Co Ltd, IQVIA Holdings Inc, Peak Pharma Solutions Inc, Pfizer Inc, Promoveo Health LLC, QFR Solutions LLC, Sales Focus Inc, Syneos Health Inc는 북미 제약 계약 판매 조직 시장에서 활동하는 선도적인 회사 중 일부입니다.
Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

5. North America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Integration of Digital Technologies

5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products

5.2 Key Market Restraints

5.2.1 Quality Issues Associated with Outsourcing

5.3 Key Market Opportunities

5.3.1 Rising Use of Telemedicine and Remote Detailing

5.4 Key Future Trends

5.4.1 Expansion in Emerging Markets

5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - North America Market Analysis

6.1 North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

7.1 Overview

7.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

7.3 Commercial Services

7.3.1 Overview

7.3.2 Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Non-Commercial Services

7.4.1 Overview

7.4.2 Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

8.1 Overview

8.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

8.3 Syndicated Modules

8.3.1 Overview

8.3.2 Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Dedicated Modules

8.4.1 Overview

8.4.2 Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

9.1 Overview

9.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

9.3 Cardiovascular Disorders

9.3.1 Overview

9.3.2 Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Oncology

9.4.1 Overview

9.4.2 Oncology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Metabolic Disorders

9.5.1 Overview

9.5.2 Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Neurology

9.6.1 Overview

9.6.2 Neurology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.7 Orthopaedic Diseases

9.7.1 Overview

9.7.2 Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.8 Infectious Diseases

9.8.1 Overview

9.8.2 Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

10.1 Overview

10.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

10.3 Biopharmaceutical Companies

10.3.1 Overview

10.3.2 Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Pharmaceutical Companies

10.4.1 Overview

10.4.2 Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Pharmaceutical Contract Sales Organizations Market - Country Analysis

11.1 North America

11.1.1.1 North America Pharmaceutical Contract Sales Organizations Market, by Country

11.1.1.2 US

11.1.1.2.1 US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.2.2 US: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.2.3 US: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.2.4 US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.2.5 US: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.3 Canada

11.1.1.3.1 Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.3.2 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.3.3 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.3.4 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.3.5 Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.4 Mexico

11.1.1.4.1 Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.4.2 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.4.3 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.4.4 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.4.5 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

12.1 Overview

12.2 Growth Strategies

12.2.1 Overview

13. Company Profiles

13.1 CMIC Holdings Co Ltd

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Axxelus Inc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 IQVIA Holdings Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Peak Pharma Solutions Inc

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 QFR Solutions LLC

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Promoveo Health LLC

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Syneos Health Inc

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Aenova Holding GmbH

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Pfizer Inc

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Sales Focus Inc

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

?

List of Tables

Table 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation

Table 2. US: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 3. US: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 4. US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 5. US: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 6. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 7. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 8. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 9. Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 10. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 11. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 12. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 13. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market

Table 15. Glossary of Terms, North America Pharmaceutical Contract Sales Organizations Market

?

List of Figures

Figure 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation, By Country

Figure 2. North America - PEST Analysis

Figure 3. North America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

Figure 6. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

Figure 7. Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

Figure 10. Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

Figure 13. Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Oncology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Neurology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Others: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

Figure 21. Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. North America Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue (2022) (US$ Million)

Figure 24. North America Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)

Figure 25. US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 27. Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

1. Aenova Holding GmbH

2. Axxelus Inc

3. CMIC Holdings Co Ltd

4. IQVIA Holdings Inc

5. Peak Pharma Solutions Inc

6. Pfizer Inc

7. Promoveo Health LLC

8. QFR Solutions LLC

9. Sales Focus Inc

10. Syneos Health Inc

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Pharmaceutical Contract Sales Organizations Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
  • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440